Dr. Fred Rhode Stoddard, MD

Dr. Stoddard practices at Adventist Health Vallejo in Vallejo, California, part of Adventist Health.

Dr. Stoddard's NPI, 1356397186, was assigned on May 25, 2006. Dr. Stoddard graduated from Emory School of Medicine in 1968. Dr. Stoddard holds California license 10-00001679.

Dr. Stoddard's primary practice is Adventist Health Vallejo, at 525 Oregon St, Vallejo, CA 94590 in Solano County. The practice phone is (707) 648-2200.

Dr. Stoddard's primary practice is Adventist Health Vallejo in Vallejo, California, part of Adventist Health. The medical group on file is Adventist Health St. Helena. Dr. Stoddard's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stoddard practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Stoddard's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Stoddard is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Stoddard's licenses on file in 2 states: California and Georgia.

Dmand AI lists bipolar disorder, dementia, psychological distress, psychoses and schizophrenia among the conditions Dr. Stoddard treats.

CMS data shows 452 Medicare services from Dr. Stoddard across 5 procedure codes in 2024, for 83 Medicare patients. Medicare paid $25,844 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Stoddard in 2024. The largest group is under 65, with 63 patients. 75% of them have schizophrenia and other psychoses, and 71% have anxiety. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stoddard's median patient age at 25, with 51% women.

In 2024, Dr. Stoddard wrote 1,608 Medicare Part D claims for 92 patients. 92% of them were for generic drugs. CMS names the drug for 1,412 of them, across 37 drugs with 11 or more claims each, at $318,891 in total drug cost. In 2023, CMS named 2,172 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Stoddard for performance year 2024, reported as part of a group.

CMS Open Payments shows 334 general payments to Dr. Stoddard from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sunovion Pharmaceuticals Inc. paid the most, $1,328.

Dr. Stoddard graduated from Emory School of Medicine in 1968.

Dr. Stoddard is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Aetna and Kaiser Permanente. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.